{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:35:07Z","timestamp":1792089307458,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.medcli.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T09:07:08Z","timestamp":1541840828000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Linfoma MALT g\u00e1strico y Helicobacter pylori"],"prefix":"10.1016","volume":"152","author":[{"given":"Antonio","family":"Salar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2018.09.006_bib0305","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2018.09.006_bib0310","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","article-title":"Malignant lymphoma of mucosa- associated lymphoid tissue. A distinctive type of B-cell lymphoma","volume":"52","author":"Isaacson","year":"1983","journal-title":"Cancer."},{"issue":"Suppl. 1","key":"10.1016\/j.medcli.2018.09.006_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter."},{"key":"10.1016\/j.medcli.2018.09.006_bib0320","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0889-8553(05)70130-8","article-title":"Recent developments in the epidemiology of Helicobacter pylori","volume":"29","author":"Everhart","year":"2000","journal-title":"Gastroenterol Clin North Am."},{"key":"10.1016\/j.medcli.2018.09.006_bib0325","first-page":"1352","article-title":"Kyoto Global Consensus Report on Helicobacter pylori gastritis","volume":"63","author":"Sugano","year":"2015","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0330","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0335","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014The Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0345","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto Consensus for the Treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2018.09.006_bib0350","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"112","author":"Chey","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0360","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.gastrohep.2013.01.011","article-title":"III Conferencia Espa\u00f1ola de Consenso sobre la infecci\u00f3n por Helicobacter pylori","volume":"36","author":"Gisbert","year":"2013","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0365","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.3748\/wjg.v21.i40.11221","article-title":"Diagnosis of Helicobacter pylori infection: current options and developments","volume":"21","author":"Wang","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0370","doi-asserted-by":"crossref","first-page":"e12857","DOI":"10.1111\/eci.12857","article-title":"Treatment of Helicobacter pylori infection: a clinical practice update","volume":"48","author":"Zagari","year":"2018","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.medcli.2018.09.006_bib0375","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.gastrohep.2016.05.003","article-title":"IV Conferencia Espa\u00f1ola de Consenso sobre el tratamiento de la infecci\u00f3n por Helicobacter pylori","volume":"39","author":"Gisbert","year":"2016","journal-title":"Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0380","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2018.09.006_bib0385","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/annonc\/mdf177","article-title":"Incidence of gastric B-cell lymphomas: a population-based study in Germany","volume":"13","author":"Ullrich","year":"2002","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0390","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2018.09.006_bib0395","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon","year":"1993","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2018.09.006_bib0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1470-2045(02)00651-4","article-title":"Gastric MALT lymphoma: from aetiology to treatment","volume":"3","author":"Du","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0405","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2005.03.083","article-title":"Helicobacter pylori and MALT lymphoma","volume":"128","author":"Farinha","year":"2005","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2018.09.006_bib0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1703","article-title":"Gastrointestinal lymphoma: where morphology meets molecular biology","volume":"205","author":"Isaacson","year":"2005","journal-title":"J Pathol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0415","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","article-title":"Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins","volume":"115","author":"Craig","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2018.09.006_bib0420","doi-asserted-by":"crossref","first-page":"e51681","DOI":"10.1371\/journal.pone.0051681","article-title":"Study of regulatory T-cells in patients with gastric MALT lymphoma: influence on treatment response and outcome","volume":"7","author":"Garc\u00eda","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.medcli.2018.09.006_bib0425","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4321\/S1130-01082007000700006","article-title":"Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review","volume":"99","author":"Asenjo","year":"2007","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.medcli.2018.09.006_bib0430","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000208899.15859.cb","article-title":"Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study","volume":"30","author":"Salar","year":"2006","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0435","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.leu.2404479","article-title":"Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936","volume":"21","author":"Evans","year":"2007","journal-title":"Leukemia."},{"key":"10.1016\/j.medcli.2018.09.006_bib0440","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1200\/JCO.2005.02.6138","article-title":"Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab","volume":"23","author":"Salar","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0445","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/gut.2005.080523","article-title":"Wotherspoon criteria combined with B-cell clonality analysis by advanced PCR technology discriminates cryptic gastric marginal zone lymphoma from chronic gastritis","volume":"55","author":"Hummel","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0450","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0455","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bjh.14153","article-title":"Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients","volume":"174","author":"Maeshima","year":"2016","journal-title":"Br J Haematol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0460","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","article-title":"Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy","volume":"357","author":"Liu","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2018.09.006_bib0465","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/01.cco.0000432523.24358.15","article-title":"The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach","volume":"25","author":"Ferreri","year":"2013","journal-title":"Curr Op Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0470","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00573019","article-title":"Prognosis of non-Hodgkin's lymphomas with special emphasis on the staging classification","volume":"83","author":"Musshoff","year":"1975","journal-title":"Z Krebsforsch Klin Onkol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0475","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/gut.48.4.454","article-title":"Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori","volume":"48","author":"Nakamura","year":"2001","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0480","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","article-title":"Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma","volume":"5","author":"Rohatiner","year":"1994","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0485","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0490","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1200\/JCO.2005.02.3903","article-title":"Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication","volume":"23","author":"W\u00fcndisch","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0495","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/ajg.2009.314","article-title":"Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis","volume":"104","author":"Zullo","year":"2009","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0500","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/annonc\/mds643","article-title":"ESMO Consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma","volume":"24","author":"Dreyling","year":"2013","journal-title":"Ann Oncol."},{"issue":"Suppl. 6","key":"10.1016\/j.medcli.2018.09.006_bib0505","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0510","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/gut.2006.096420","article-title":"Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series","volume":"56","author":"Fischbach","year":"2007","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0515","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskone-Fourmestraux","year":"2011","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2018.09.006_bib0520","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up","volume":"117","author":"Ruskon\u00e9-Fourmestraux","year":"2015","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0525","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final Results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0530","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood-2017-07-795302","article-title":"Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma","volume":"130","author":"Salar","year":"2017","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2018.09.006_bib0535","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1080\/10428190802210692","article-title":"Persistent monoclonality after histological remission in gastric mucosa- associated lymphoid tissue lymphoma treated with chemotherapy and \/ or surgery: influence of t(11;18)(q21;q21)","volume":"49","author":"Santon","year":"2008","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.medcli.2018.09.006_bib0540","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1200\/JCO.2001.19.6.1600","article-title":"Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma","volume":"19","author":"Thiede","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0545","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2036.2006.02827.x","article-title":"Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients","volume":"23","author":"Gisbert","year":"2006","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.medcli.2018.09.006_bib0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","article-title":"Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma","volume":"8","author":"Zullo","year":"2010","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0555","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/00365520310000582","article-title":"Early cancer of the stomach arising after successful treatment of gastric MALT lymphoma in patients with autoimmune disease","volume":"38","author":"Raderer","year":"2003","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0560","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","article-title":"High relapse rate in patients with MALT lymphoma warrants lifelong follow-up","volume":"11","author":"Raderer","year":"2005","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.medcli.2018.09.006_bib0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2559.2010.03699.x","article-title":"MALT lymphoma: many roads lead to nuclear factor-B activation","volume":"58","author":"Du","year":"2011","journal-title":"Histopathology."},{"key":"10.1016\/j.medcli.2018.09.006_bib0570","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0016-5085(00)70167-3","article-title":"Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection","volume":"118","author":"Morgner","year":"2000","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2018.09.006_bib0575","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.3748\/wjg.v21.i26.8014","article-title":"Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: a review","volume":"21","author":"Asano","year":"2015","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0580","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/jnci\/dji277","article-title":"Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma","volume":"97","author":"Chen","year":"2005","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.medcli.2018.09.006_bib0585","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1200\/JCO.2001.19.7.2041","article-title":"Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection","volume":"19","author":"Morgner","year":"2001","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.medcli.2018.09.006_bib0590","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/blood-2012-01-404194","article-title":"Helicobacter pylori eradication therapy is effective in the treatment of early-stage H. pylori-positive gastric diffuse large B-cell lymphomas","volume":"119","author":"Kuo","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.medcli.2018.09.006_bib0595","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/carcin\/bgi334","article-title":"A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma","volume":"27","author":"Suzuki","year":"2006","journal-title":"Carcinogenesis."},{"key":"10.1016\/j.medcli.2018.09.006_bib0600","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2012-06-438424","article-title":"Helicobacter pylori eradication as exclusive treatment for limited-stage gastric diffuse large B-cell lymphoma: results of a multicenter phase 2 trial","volume":"120","author":"Ferreri","year":"2012","journal-title":"Blood."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318305669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775318305669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:48:48Z","timestamp":1758419328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775318305669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0025775318305669"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2018.09.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linfoma MALT g\u00e1strico y Helicobacter pylori","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}